Renovo Share Discussion Threads

[gnnmartin] 21/12/2012 10:18

Interesting. We seem to be turning into an investment trust. I had expected Renovo would reverse into a business that wanted a quote and some cash. I'm still happy to go along for the ride.
Nigel Martin

[alimo] 17/12/2012 01:20

I wonder what we spent developing Prevascar, before we go whoopee! Also, how much else was included in the 'assets'. We need to know what patents have been released with the assets. I suppose we'll get to know some more about the quality of who is left, by the quality of deals they make. It is interesting that others want our research. I wonder why, when we decided not to proceed with it.

[argylerich] 11/6/2012 11:26

I don't think there is anything being hidden here, or anything surprising going to happen. In a volatile market, in theory it's safe money 'in the bank' (although it does depend which one I guess!)
As for the buyback, when the shares are below the level of cash per share, it makes sense for them to do, as the small difference goes back in the pot.

[alimo] 11/6/2012 11:18

I think the Prof may still be a large holder. No?

Maybe he'll be helping the remaining BoD to look for the other coy that will go on with the IP and arrange the trials to succeed without Shire influence. Shire think they have bought into another scars biotechnology that is better'n RNVO, but maybe they will find the same problem. Maybe the P3 trial for Juvista was just too, and unesessarily, uncontrolled, to have a successful outcome. Maybe intentionally so - will we ever be able to discover?

Why are we buying so many of our own shares and putting them into treasury? Does this make us easier to merge with another? Why are the big shareholders so keen to keep hold of their large holdings, while the minnows give up the wait and sell to them?

Can't help but feel that there is a silver lining somewhere that the people in the know seem shy to disclose to us minions. BUT what of the 'fid' duty that they all owe to ALL shareholders. If we have one, our Co Sec also has a duty to disclose who has all the skills in guiding us now. Even our Nominated Adviser has duties of disclosure even if we are an AIM company now.

Meanwhile, lots of questions remain unanswered and the minnows are eaten up by the big guys ( and we pray that they aren't sharks! ). The IP had huge value and testing over decades and the biochemists involved seem to have fallen on their feet, cos I don't hear too much shouting.

So onwards, and upwards we go, into a future that only a few know the direction.

[argylerich] 13/5/2012 17:20

But don't you need to employ someone to make a decision first? ;)

Is there anybody left?

[the_doctor] 13/5/2012 16:31

'Can't see there being any acquisitions, as they have no staff or ongoing operations to speak of'

that's what they acquire!?

[argylerich] 12/5/2012 00:58

This is no more than a cash shell now, with 29m in the bank.

Can't see there being any acquisitions, as they have no staff or ongoing operations to speak of.

They're just looking to either be taken over or return the cash, hence the buy-back.

[danwaits] 11/5/2012 23:59

Genuine question and not a moan. Can anyone explain to me the rationale in continuing to purchase our own shares? 'Seems to me that its just diluting our warchest for any planned acquisitions.

[argylerich] 10/5/2012 16:42

Huge volume today, RNS due?

[hollerich1] 16/4/2012 17:13

is it air con or renovo con.

[hollerich1] 16/4/2012 17:13

con is in the air.

[gnnmartin] 16/4/2012 12:28

Pity. It is astonishing to naive outsiders like myself how treatments can be so promising in early stages and then so ineffective in the final trial.
Nigel Martin

[miguelh21] 17/3/2012 22:04

I do think it is crazy that keloids do not have decent treatment but RNVO has no solutions. By the way its not only blacks that can suffer from keloids

[alimo] 13/3/2012 16:04

I wish they'd share some of their confidence with us.

The directors should know by now how the trial for Prevascar is progressing. It will be interesting to see how they handle the release of information about this trial during H1 2012 (we are already half way through this period). Can we allow ourselves to think that Prevascar just might be able to do what Juvista was supposed to do? I hope so for our sake, yes, but also for the sake of the millions of people of African origin that this biotech is designed to help.

I'm also hoping that all the research on Juvista will still be found to work well for children, and for those adults that may have the skin that accepts what Juvista does well. When I look at the Phase 1 & 2 photos for Juvista, I can't be anything but confident that there must be considerable value in all the Juvista research done so far.

I wonder if the board are really looking world-wide for buyers, for all the clinical programmes they have been working on so far. What value does the pre-clinical research work have? There is every possibility that some block-buster biotech is lurking in the IP chain that hasn't been brought to the light of day yet. Who is looking after all the patents we have already filed? If all the research employees and Prof Ferguson have gone, who is there to advise the Board on what a good offer is, or what a poor offer is.

Prof Ferguson was raving about Juvidex in 2010/11. Juvidex we were led to believe has such an enormous potential to add quality to many cosmetic facial products (even aftershave!), you'd think the huge number of facial product manufacturers would be falling over each other to get their hands on the stuff by now.

Why is there no positive news being released? Is the share price being kept low for reasons only privvy to the large shareholders?

Is Prof Ferguson still the rudder for this ship which still has a full cargo of IP in its holds? Hopefully none of it is being jettisoned. £millions of our cash has been spent on it, so we want good value, and not a fire sale!

Surely, if our directors don't have what it takes to keep this ship afloat without jettisoning the IP, they must have the skills to search out another ships company that has. Xenetic Biosciences(XEN) recently sailed to Russia to get more money to carry on, and they have Germany and India on board as well. If the two of us could work together we could help each other reach our full potential among the huge populations, and nouveaux riche of the future economies of the world. Sounds good, eh?

This has to be better than flapping around in murky waters, just waiting for our remaining team to announce a done deal that suits only the few, like so many done deals are. If the founders have jumped ship into their lifeboats then we who remain may be in the care of wheeler-dealers and accountants looking to finish us off as quickly and quietly as possible, within their investment tolerances. There is room in our plan going forward from here to seek for and develop the corporate M&A potential for RNVO. Now ROVONEX sounds much better, and could have a very positive future. Who can do the maths?

I wonder where and how Shire got hold of the tissue repair bioscience technology for treating skin burns, and presumably other skin trauma? I hope the stuff they use is in some way traceable back to an RNVO patent. Who's checking, and does anybody care?

[grahamg8] 12/3/2012 08:13

RNVO still buying, price paid inched up to 16.8p. As Directors are supposed to work in the best interests of shareholders this must mean the NAV is >16.8ppp or am I being naive? Charles Davies had 120k till 16 November, now up to 13.58m. Henderson holding firm with 53.4m. JP Morgan increased from 10.65m to 18.998m. And as far as I can tell Ferguson still has 19.91m. Charles Davies is the most interesting as he seems to have had a large holding during 2011, sold down hard and then bought back in. For PIs we would hope that the larger holders have a better feel for the true value here and that there will be some more to come as the year unfolds.

[sir rational] 07/3/2012 15:53

How do you get to 30p?

[smith99] 07/3/2012 15:52

good enough for me mate, we just seem to have got stuck at 16.75 - 17.0p

I dont suppose you would like to hazzard a guess and look into your crystal ball to see when that is likely to happen

[hollerich1] 07/3/2012 11:09

hold to the last smithy, there is light at the end of the tunnel, as this stands as at today the share price is worth 30p.

[smith99] 07/3/2012 09:50

where do any shareholder go from here ? I still hold a few of these (from before the disaster), just wondered what I should be doing with them ?

Any suggestions ?

[alimo] 04/2/2012 23:20

continued from 8807

And another thing; surely it's a bit odd that Prof Mark Ferguson lands a prestige science job so soon after his prestige research turns out to be unsuccessful, after years of plaudits for the breakthrough discoveries he and his team made that have the potential to improve the looks of many thousands of adults, children, and black people with unsightly scars. You'd think he would be the last bioscientist that any government would want to appoint to such an important position. Maybe all the IP his team discovered is still extremely valuable after all.

Is there a London Stock Exchange or Government in depth watchdog that can investigate why all the products are being closed down as being useless, when even only just a year ago we were being assured that they were all on target to report exciting success stories. Do people call in independent experts to check what we are told is absolutely the truth, and nothing but the truth.

Why is it only the very big shareholders that are wanting the shares, and quite confidently putting the investments of other smaller people at risk? How can they and what do they read between the lines in the reports that have been issued so far?

[hollerich1] 02/2/2012 11:55

i have always sensed a con re this whole unsuccessfull story.